Oscar Health, Inc. (OSCR)
NYSE:OSCR
Want to see OSCR full AI Analyst Report?
Earnings Data
Report Date
Aug 06, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.33Last Year’s EPS
-0.89Same Quarter Last Year
Based on 10 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call communicated robust top-line growth, record membership, strong profitability and a healthy balance sheet, with management highlighting AI/product initiatives and new distribution channels (Lucie, ICHRA X). Primary near-term concerns center on elevated early-year risk adjustment, seasonally low claims that affect RA and revenue timing, some prior-period reserve variability, and expected churn normalization. Management expressed confidence—reaffirming full-year guidance—and emphasized improving visibility after Q2 claims and Wakely reports.Company Guidance
Strong Revenue Growth
Total revenue of $4.6 billion in Q1 2026, an increase of 53% year-over-year driven by higher membership and rate increases.
Record Membership Expansion
Ended Q1 with ~3.2 million members, a 56% year-over-year increase; started Q2 with ~3.0 million paid members, driven by above-market growth during open enrollment and solid retention.
Significant Profitability Improvements
Earnings from operations of $704 million in Q1 (nearly 2.5x year-over-year improvement, +$407 million), net income of ~$679 million ($2.07 per diluted share), the highest in company history (+$404 million YoY), and adjusted EBITDA of $727 million (+$398 million YoY).
Improved Loss Ratios and Margins
Medical Loss Ratio (MLR) improved 490 basis points year-over-year to 70.5% in Q1; operating margin of 15.2% (+540 basis points YoY).
Lower SG&A and Operating Leverage
SG&A expense ratio improved by 60 basis points year-over-year to 15.2% in Q1 (lowest in company history); SG&A dollars grew 46% YoY, showing fixed-cost leverage against revenue growth.
Strong Capital and Cash Position
Cash and investments of approximately $8.1 billion (including $279 million at the parent); insurance subsidiaries had ~$1.7 billion of capital and surplus, including $809 million of excess capital.
Product, Technology and Distribution Momentum
Launched transparency tools (real-time drug pricing), scaled AI/bilingual voice agents, launched ICHRA X data exchange and the Lucie Health Marketplace (carrier-agnostic shopping platform); management expects modest 2026 contribution and meaningful long-term opportunity.
Reaffirmed Full-Year Guidance
Company reaffirmed full-year 2026 guidance: total revenues $18.7B–$19.0B; full-year MLR guidance 82.4%–83.4%; SG&A ratio guidance 15.8%–16.3%; earnings from operations $250M–$450M (with adjusted EBITDA expected ~ $115M higher).
OSCR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
OSCR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2026 | $17.94 | $19.84 | +10.59% |
Feb 10, 2026 | $12.66 | $12.88 | +1.74% |
Nov 06, 2025 | $17.03 | $16.56 | -2.76% |
Aug 06, 2025 | $13.82 | $14.34 | +3.76% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Oscar Health, Inc. (OSCR) report earnings?
Oscar Health, Inc. (OSCR) is schdueled to report earning on Aug 06, 2026, After Close (Confirmed).
What is Oscar Health, Inc. (OSCR) earnings time?
Oscar Health, Inc. (OSCR) earnings time is at Aug 06, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is OSCR EPS forecast?
OSCR EPS forecast for the fiscal quarter 2026 (Q2) is 0.33.
